HAE HAEMONETICS CORP: institutional ownership and insider trading
358 funds reported holding $4.21B of HAEMONETICS CORP in their latest 13F filings; in Q2 2026 funds net bought $175M, with 52 new positions and 44 funds selling out; over the last 12 months insiders bought $98.8K and sold $0 on the open market.
Famous investors holding HAE
- Izzy Englander (Millennium Management): $50.3M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $4.48M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $116M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $9.75M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $2.70M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $794K, 0.0% of the portfolio
Largest institutional holders of HAE
- BlackRock, Inc. (BLK) — $443M
- VANGUARD GROUP INC — $382M
- Neuberger Berman Group LLC — $313M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $191M
- AQR CAPITAL MANAGEMENT LLC — $165M
- ARIEL INVESTMENTS, LLC — $155M
- VANGUARD CAPITAL MANAGEMENT LLC — $154M
- STATE STREET CORP (STT, STT-PG) — $136M
- DIMENSIONAL FUND ADVISORS LP — $119M
- CITADEL ADVISORS LLC — $116M
Recent HAE insider trades
- Nov 10, 2025: Kroll Mark W bought 1,400 shares ($98.8K)
5%+ owners
- Vanguard Portfolio Management: 5.6% (Schedule 13G, filed Apr 29, 2026)
- Vanguard Capital Management: 5.3% (Schedule 13G, filed Apr 30, 2026)